5-甲氧基-2-甲基-1-丙基-1H-吲哚-3-羧酸 | 17826-24-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 5-甲氧基-2-甲基-1-丙基-1H-吲哚-3-羧酸
• 英文名称: 1-Propyl-2-methyl-3-carboxy-5-methoxyindol
• 英文别名: 5-methoxy-2-methyl-1-propyl-1H-indole-3-carboxylic acid；5-methoxy-2-methyl-1-propylindole-3-carboxylic acid
• CAS: 17826-24-3
• 化学式: C₁₄H₁₇NO₃
• mdl: MFCD08246124
• 分子量: 247.294
• InChiKey: GTRKZYWTBFQHCT-UHFFFAOYSA-N

物化性质

• 熔点：
  164-165 °C
• 沸点：
  441.7±40.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.357
• 拓扑面积：
  51.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  5-甲氧基-2-甲基-1-丙基-1H-吲哚-3-羧酸 、 methyl γ-aminocrotonate trifluoroacetate 在 1-羟基苯并三唑 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 以47.6%的产率得到methyl (E)-4-(5-methoxy-2-methyl-1-propyl-1H-indole-3-carboxamido)but-2-enoate
  参考文献：
  名称：

  A Small Molecule That Switches a Ubiquitin Ligase From a Processive to a Distributive Enzymatic Mechanism

  摘要：

  E3 ligases are genetically implicated in many human diseases, yet E3 enzyme mechanisms are not fully understood, and there is a strong need for pharmacological probes of E3s. We report the discovery that the HECT E3 Nedd4-1 is a processive enzyme and that disruption of its processivity by biochemical mutations or small molecules switches Nedd4-1 from a processive to a distributive mechanism of polyubiquitin chain synthesis. Furthermore, we discovered and structurally characterized the first covalent inhibitor of Nedd4-1, which switches Nedd4-1 from a processive to a distributive mechanism. To visualize the binding mode of the Nedd4-1 inhibitor, we used X-ray crystallography and solved the first structure of a Nedd4-1 family ligase bound to an inhibitor. Importantly, our study shows that processive Nedd4-1, but not the distributive Nedd4-1:inhibitor complex, is able to synthesize polyubiquitin chains on the substrate in the presence of the deubiquitinating enzyme USP8. Therefore, inhibition of E3 ligase processivity is a viable strategy to design E3 inhibitors. Our study provides fundamental insights into the HECT E3 mechanism and uncovers a novel class of HECT E3 inhibitors.

  DOI：

  10.1021/jacs.5b06839